Global MedTech company, Mölnlycke Health Care, has officially opened its new global headquarters in Mölndal, Gothenburg. The newly built 16,000 sqm facility has a capacity for 1,000 employees and is located in the heart of the GoCo Health Innovation City, which continues to expand. The new life science hub already gathers around 100 companies and is a workplace for thousands of life science professionals.
“Placing Mölnlycke together with other key players in life science is a game-changer. It opens up entirely new possibilities for us to collaborate with experts from various disciplines, and the chance to practice what we preach: embracing partnerships,” said Zlatko Rihter, CEO of Mölnlycke in statement when the new headquarters was unveiled.
The new facility triples Mölnlycke’s laboratory space, significantly expanding its capacity for research and development. The company said it will also enhance its ability to attract top global talent.
The grand opening brought together business partners and thought leaders from industry, academia and healthcare. A highlight was a panel discussion entitled “Who should lead the transformation towards sustainable healthcare,” featuring:
- Petra Noreback, State Secretary to the Minister for Social Affairs and Public Health
- Christian Cederholm, Chief Executive Officer of Investor AB
- Boubou Hallberg, Chief Executive Officer of Sahlgrenska University Hospital
- Jenny Nyström, Dean of Sahlgrenska Academy at the University of Gothenburg
- Emma Wright, Chief Medical Officer, Mölnlycke
- Zlatko Rihter, Chief Executive Officer, Mölnlycke
The discussion underscored the urgency and opportunity of transformation towards sustainable healthcare, as well as the critical role of cross-sector collaboration to achieve this.
Zlatko Rihter, CEO, Mölnlycke commented “We’re proud to open the doors of our new HQ for this special evening. Our move to GoCo Health Innovation City was driven by our ambition to foster partnerships to speed up innovation towards sustainable healthcare; and this was echoed by the panel who spoke about the importance of collaboration to drive true change that benefits both people and planet.”
The new headquarters triples Mölnlycke’s laboratory space, significantly expanding its capacity for research and development. Designed for flexibility, collaboration and employee wellbeing, the headquarters sets a new standard for sustainable and future-ready workplaces. Positioned within one of Sweden’s most dynamic life science ecosystems, the facility enhances Mölnlycke’s ability to attract top global talent and co-create with health innovators.
“This wonderful building is more than just bricks and mortar—it embodies the boldness and passion that define Mölnlycke,” Rihter added. “We’re excited to be part of a community that shares our vision of smarter, safer and more sustainable healthcare.”
Mölnlycke Health Care was founded in Sweden in 1849. Today it is a leading MedTech company employing around 8,600 people. Its products and solutions are used daily by hospitals, healthcare providers and patients in over 100 countries around the world.
The firm specialises in innovative solutions for wound care and surgical procedures. Last year, its sales amounted to EUR 2 billion, up from EUR 1 billion in 2012.
The Gothenburg region has two main hubs for life science and health innovation: GoCo Health Innovation City and Medicinareberget (Medicine hill). GoCo gathers several large corporations including AstraZeneca, Wellspect Healthcare, FujireBio and Mölnlycke Health Care – and a growing number of innovative SMEs and service providers. New facilities, including Thermo Fisher Scientific’s new bioanalytical lab and CCRM Nordic's new lab for commercialising advanced therapies, are under construction.
The area around Medicinareberget is a hub for education, research and innovation housing university campuses, one of Europe’s largest university hospitals, a science park and nearly 300 companies. The area is also expanding with new buildings and refurbishments both underway and planned.
